Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

19 works

Work: The edible tomato COVID-19 vaccine, TOMAVAC, induces neutralising IgGs

  1. Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan

    Mirzakamol S. Ayubov, Zabardast T. Buriev, Mukhammadjon K. Mirzakhmedov +5

    ArticleSARS-CoV-2 and COVID-19 ResearchPLoS ONE20229 citations
    ABI

  2. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

    Lianpan Dai, Tianyi Zheng, Kun Xu +18

    Article20208 citations
    ABI

  3. Untitled

    Other8 citations
    ABI

  4. Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults

    Lianpan Dai, Lidong Gao, Lifeng Tao +27

    Article20227 citations
    ABI

  5. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

    Shilong Yang, Yan Li, Lianpan Dai +26

    Article20216 citations
    ABI

  6. Covid‐19 vaccines and variants of concern: A review

    Ikbel Hadj Hassine

    Review article20214 citations
    ABI

  7. A plant‐derived edible vaccine against hepatitis B virus

    Józef Kapusta, A. Modelska, Magdalena Figlerowicz +7

    Article19992 citations
    ABI

  8. Novel Transgenic Rice-Based Vaccines

    Tatsuhiko Azegami, Hiroshi Itoh, Hiroshi Kiyono +1

    Review article20142 citations
    ABI

  9. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination

    Tomonori Nochi, Hidenori Takagi, Yoshikazu Yuki +11

    Article20072 citations
    ABI

  10. Severe acute respiratory syndrome (SARS) S protein production in plants: Development of recombinant vaccine

    Natalia Pogrebnyak, Maxim Golovkin, V. M. Andrianov +4

    Article20052 citations
    ABI

  11. Chloroplast‐derived vaccines against human diseases: achievements, challenges and scopes

    Andreas Günter Lössl, Mohammad Tahir Waheed

    Review article20112 citations
    ABI

  12. Current state and challenges in developing oral vaccines

    Julia E. Vela Ramirez, Lindsey A. Sharpe, Nicholas A. Peppas

    Review article20172 citations
    ABI

  13. Edible Vaccines: Promises and Challenges

    Vrinda M Kurup, Jaya Thomas

    Review article20192 citations
    ABI

  14. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction

    Chee Wah Tan, Wan Ni Chia, Xijian Qin +13

    Article20202 citations
    ABI

  15. An edible vaccine development for coronavirus disease 2019: the concept

    Sayed Sartaj Sohrab

    Review article20202 citations
    ABI

  16. Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates

    Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj +17

    Article20212 citations
    ABI

  17. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

    John S. Tregoning, Katie E. Flight, Sophie L. Higham +2

    Review article20212 citations
    ABI

  18. Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy

    Dennis Christensen, Charlotta Polacek, Daniel J. Sheward +17

    Article20222 citations
    ABI

  19. Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic

    Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova +3

    Review article20222 citations
    ABI